TFA
PCVX icon

Transamerica Financial Advisors’s Vaxcyte PCVX Stock Holding History

Transamerica Financial Advisors’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44K Buy
42
+11
+35% +$597 ﹤0.01% 1268
2026
Q1 		$1.8K Buy
31
+28
+933% +$1.52K ﹤0.01% 1233
2025
Q4 		$138 Hold
3
– – ﹤0.01% 1605
2025
Q3 		$108 Buy
+3
New +$99 ﹤0.01% 1513

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Transamerica Financial Advisors's PCVX Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Vaxcyte (PCVX) stake by 35% in Q2 2026, buying an estimated $597 and bringing the position to 42 shares worth $2.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1268.

Transamerica Financial Advisors first reported a position in PCVX in Q3 2025 and has held it in 4 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Transamerica Financial Advisors held 42 shares of Vaxcyte worth $2.44K as of Q2 2026.
  • Transamerica Financial Advisors bought 11 Vaxcyte shares in Q2 2026, an estimated $597.
  • Vaxcyte made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1268 holding.
  • Transamerica Financial Advisors first reported a position in Vaxcyte in Q3 2025 and has held it in 4 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.